{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:23:12Z","timestamp":1779250992714,"version":"3.51.4"},"reference-count":36,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14734","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T12:07:13Z","timestamp":1728648433000},"source":"Crossref","is-referenced-by-count":4,"title":["Treatment of acute myeloid leukemia with active pulmonary tuberculosis with venetoclax\u2011based anti\u2011acute myeloid leukemia regimen combined with an intensive and then individualized anti\u2011tuberculosis regimen: A report of two cases"],"prefix":"10.3892","volume":"28","author":[{"given":"Lin","family":"Ji","sequence":"first","affiliation":[{"name":"Department of Oncology and Hematology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang 310003, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang 310003, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang 310003, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang 310003, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang 310003, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang 310003, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"key":"key20241112101947_b1-ol-28-6-14734","article-title":"Global Tuberculosis report","author":"World Health Organization (WHO)","year":"2023"},{"key":"key20241112101947_b2-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","article-title":"Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Shimony","year":"2023","journal-title":"Am J Hematol"},{"key":"key20241112101947_b3-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"key":"key20241112101947_b4-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1182\/bloodadvances.2020001920","article-title":"American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults","volume":"4","author":"Sekeres","year":"2020","journal-title":"Blood Adv"},{"key":"key20241112101947_b5-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ajh.24246","article-title":"Acute myeloid leukemia-major progress over four decades and glimpses into the future","volume":"91","author":"Kantarjian","year":"2016","journal-title":"Am J Hematol"},{"key":"key20241112101947_b6-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1002\/cncr.20698","article-title":"Investigation of healthcare-associated transmission of Mycobacterium tuberculosis among patients with malignancies at three hospitals and at a residential facility","volume":"101","author":"Malone","year":"2004","journal-title":"Cancer"},{"key":"key20241112101947_b7-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s12288-017-0875-z","article-title":"Analysis of clinical profile and outcome of tuberculosis in patients with acute leukemia","volume":"34","author":"Jain","year":"2018","journal-title":"Indian J Hematol Blood Transfus"},{"key":"key20241112101947_b8-ol-28-6-14734","first-page":"705","article-title":"Chinese guidelines for diagnosis and treatment of adult acute myeloid leukemia (not APL) (2023)","volume":"44","author":"Leukemia & Lymphoma Group, Chinese Society of Hematology and Chinese Medical Association","year":"2023","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"key20241112101947_b9-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"1180757","DOI":"10.3389\/fmed.2023.1180757","article-title":"A case report of complete remission of acute myeloid leukemia combined with DNMT3A, FLT3-TKD, and IDH2 gene mutations and active pulmonary tuberculosis treated with homeharringtonine + venetoclax + azacytidine","volume":"10","author":"Ji","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"key20241112101947_b10-ol-28-6-14734","first-page":"881","article-title":"Expert consensus on the application of next-generation sequencing in hematological neoplasms (2018)","volume":"39","author":"Hematology Oncology Committee of China Anti-Cancer Association; Chinese Society of Hematology Chinese Medical Association; Chinese Society of Pathology Chinese Medical Association","year":"2018","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"key20241112101947_b11-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.2147\/IDR.S388568","article-title":"Diagnostic Efficacy of T-SPOT.TB for active tuberculosis in adult: A retrospective study","volume":"15","author":"Sun","year":"2022","journal-title":"Infect Drug Resist"},{"key":"key20241112101947_b12-ol-28-6-14734","first-page":"558","article-title":"Consensus of Chinese experts on morphologic analysis of blood cells","volume":"34","author":"Experimental Diagnosis Group and Hematology Society Chinese Medical Association","year":"2013","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"key20241112101947_b13-ol-28-6-14734","first-page":"1001","article-title":"Expert consensus on minimal residual disease detection of acute leukemia and plasma cell neoplasms by multi-parameter flow cytometry","volume":"38","author":"Chinese Society of Immunology and Clinical Flow Cytometry Group","year":"2017","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"key20241112101947_b14-ol-28-6-14734","first-page":"1076","article-title":"Clinical research progress of hematological malignancies complicated with active tuberculosis","volume":"34","author":"Li","year":"2013","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"key20241112101947_b15-ol-28-6-14734","article-title":"WHO operational handbook on tuberculosis Module 2","volume-title":"Screening Systematic screening for tuberculosis disease","author":"World Health Organization (WHO)","year":"2021"},{"key":"key20241112101947_b16-ol-28-6-14734","first-page":"7","article-title":"A comprehensive study on the correlation of treatment, diagnosis and epidemiology of tuberculosis and lung cancer","volume":"22","author":"Sheikhpour","year":"2023","journal-title":"Tanaffos"},{"key":"key20241112101947_b17-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1017\/S0950268822000176","article-title":"Comparison of clinical and imaging features between pulmonary tuberculosis complicated with lung cancer and simple pulmonary tuberculosis: A systematic review and meta-analysis","volume":"150","author":"Sun","year":"2022","journal-title":"Epidemiol Infect"},{"key":"key20241112101947_b18-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s10096-023-04637-2","article-title":"Detection of serum Aspergillus-specific IgM and IgG antibody levels for the diagnosis of chronic pulmonary aspergillosis developed in patients with tuberculosis","volume":"42","author":"Mei","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key20241112101947_b19-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1067\/j.cpradiol.2019.09.007","article-title":"Imaging features of pulmonary leukemic infiltration with comparison of lymphoid and myeloid leukemias","volume":"50","author":"Gosangi","year":"2021","journal-title":"Curr Probl Diagn Radiol"},{"key":"key20241112101947_b20-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s11604-021-01151-3","article-title":"CT classification of acute myeloid leukemia with pulmonary infiltration","volume":"39","author":"Yoshifuji","year":"2021","journal-title":"Jpn J Radiol"},{"key":"key20241112101947_b21-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1164\/arrd.1977.116.4.627","article-title":"Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium tuberculosis","volume":"116","author":"Dickinson","year":"1977","journal-title":"Am Rev Respir Dis"},{"key":"key20241112101947_b22-ol-28-6-14734","first-page":"438","article-title":"Application of Bcl-2 inhibitor venetoclax in acute myeloid leukemia","volume":"42","author":"Zhang","year":"2021","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"key20241112101947_b23-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N Engl J Med"},{"key":"key20241112101947_b24-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1182\/blood.2020009081","article-title":"Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS production","volume":"138","author":"Lee","year":"2021","journal-title":"Blood"},{"key":"key20241112101947_b25-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/jha2.663","article-title":"Venetoclax with decitabine or azacitidine in the first-line treatment of acute myeloid leukemia","volume":"4","author":"Bouligny","year":"2023","journal-title":"EJHaem"},{"key":"key20241112101947_b26-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s11912-022-01299-9","article-title":"Older patients with acute myeloid leukemia deserve individualized treatment","volume":"24","author":"De Leeuw","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"key20241112101947_b27-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"490","DOI":"10.21037\/atm-22-1459","article-title":"Synergistic efficacy of homoharringtonine and venetoclax on acute myeloid leukemia cells and the underlying mechanisms","volume":"10","author":"Yuan","year":"2022","journal-title":"Ann Transl Med"},{"key":"key20241112101947_b28-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3324\/haematol.2018.208835","article-title":"Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1\/TET1\/5hmC","volume":"105","author":"Li","year":"2020","journal-title":"Haematologica"},{"key":"key20241112101947_b29-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"S1517","DOI":"10.1182\/blood-2023-179275","article-title":"Venetoclax combined with homoharringtonine, cytarabine, and aclacinomycin (HAAV) as induction therapy in newly diagnosed young adult acute myeloid leukemia","volume":"142","author":"Zhou","year":"2023","journal-title":"Blood"},{"key":"key20241112101947_b30-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"S4272","DOI":"10.1182\/blood-2023-179009","article-title":"Venetoclax combined with homoharringtonine and cytarabine (HAV) as induction treatment in elder or intensive chemotherapy (IC) ineligible patients with newly diagnosed acute myeloid leukemia","volume":"142","author":"Liu","year":"2023","journal-title":"Blood"},{"key":"key20241112101947_b31-ol-28-6-14734","first-page":"812","article-title":"The value of venetoclax blood concentration monitoring in the treatment of acute myeloid leukemia and the efficacy and safety of combined azacytidine in the treatment of acute myeloid leukemia","volume":"35","author":"Li","year":"2022","journal-title":"J Clin Hematol"},{"key":"key20241112101947_b32-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13045-023-01437-1","article-title":"Venetoclax combined with azacitidine and homoharringtonine in relapsed\/refractory AML: A multicenter, Phase 2 trial","volume":"16","author":"Jin","year":"2023","journal-title":"J Hematol Oncol"},{"key":"key20241112101947_b33-ol-28-6-14734","first-page":"290","article-title":"Hypomethylating agents+venetoclax induction therapy in acute myeloid leukemia unfit for intensive chemotherapy-novel avenues for lesser venetoclax duration and patients with baseline infections from a developing country","volume":"11","author":"Mirgh","year":"2021","journal-title":"Am J Blood Res"},{"key":"key20241112101947_b34-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/oncolo\/oyac135","article-title":"Venetoclax and hypomethylating agents as first-line treatment in newly diagnosed patients with AML in a predominately community setting in the US","volume":"27","author":"Vachhani","year":"2022","journal-title":"Oncologist"},{"key":"key20241112101947_b35-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.3390\/molecules26237153","article-title":"Biological Effects of Quinolones: A family of broad-spectrum antimicrobial agents","volume":"26","author":"Millanao","year":"2021","journal-title":"Molecules"},{"key":"key20241112101947_b36-ol-28-6-14734","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3390\/pathogens11050492","article-title":"Diverse cell death mechanisms are simultaneously activated in macrophages infected by virulent mycobacterium tuberculosis","volume":"11","author":"Ramon-Luing","year":"2022","journal-title":"Pathogens"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T08:19:56Z","timestamp":1731399596000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,10,11]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14734","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,11]]},"article-number":"601"}}